RecruitingPhase 2NCT04746209

Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Medical College of Wisconsin
Principal Investigator
Rachel Phelan, MD, MPH, F.N.P
Medical College of Wisconsin
Intervention
Alpha/Beta T-cell and B-cell depleted HCT(device)
Enrollment
25 enrolled
Eligibility
25 years · All sexes
Timeline
20212029

Study locations (1)

Collaborators

Amgen · University of Wisconsin, Madison

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04746209 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials